Willard H. Dere - 04 Apr 2024 Form 4 Insider Report for Seres Therapeutics, Inc. (MCRB)

Role
Director
Signature
/s/ Thomas J. DesRosier, Attorney-in-Fact
Issuer symbol
MCRB
Transactions as of
04 Apr 2024
Transactions value $
$0
Form type
4
Filing time
08 Apr 2024, 16:45:12 UTC
Previous filing
03 Apr 2024
Next filing
23 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MCRB Stock Option (right to buy) Award $0 +60,000 $0 60,000 04 Apr 2024 Common Stock 60,000 $0.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of April 4, 2025 or the day immediately prior to the company's 2025 annual meeting of shareholders.